Close Menu

stock offering

NEW YORK (GenomeWeb News) – Rosetta Genomics reported after the close of the market on Friday that its revenues for full-year 2012 nearly doubled year over year.
Rosetta also announced a deal with Cantor Fitzgerald to serve as its agent in the sale of up to $5.9 million of its stock.

NEW YORK (GenomeWeb News) – CombiMatrix has signed an agreement with an institutional investor for a registered direct offering that is expected to provide the firm with $2 million in gross proceeds, or $1.76 million in net proceeds.

NEW YORK (GenomeWeb News) – NeoGenomics today announced the public offering of 3.15 million shares of its common stock at $3.00 per share.

NEW YORK (GenomeWeb News) – Trovagene said in a regulatory filing on Wednesday that it is publicly offering $6.1 million of its common stock.

NEW YORK (GenomeWeb News) – BG Medicine has completed a public offering of 6 million shares of its common stock, raising net proceeds of around $12.8 million.

NEW YORK (GenomeWeb News) – BG Medicine today announced a public offering of its stock that it expects to bring in $11.1 million in net proceeds.

Alnylam to Sell $125M in Stock

Premium

Alnylam Pharmaceuticals this week announced that it will raise $125 million through the public sale of common stock.

NEW YORK (GenomeWeb News) – Danaher today said that Steven Rales, its chairman of the board, will sell 15 million shares of Danaher common stock under SEC Rule 144.
The rule governs the public resale of restricted and control securities.

NEW YORK (GenomeWeb News) – Rosetta Genomics said today that the underwriter for its recent public offering has exercised an overallotment option to purchase 825,000 additional shares of the company's

Fluidigm's public offering of more than 4 million shares of stock, which this week netted the company $56.1 million in proceeds, is intended primarily to fund an acquisition that would quickly bolster the company's assay and reagent offering, a company spokesperson said this week

Pages

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.